[ad_1]
Cencora (NYSE:COR – Get Free Report) and SBC Medical Group (NASDAQ:SBC – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, risk, earnings, profitability, valuation, dividends and institutional ownership.
Analyst Ratings
This is a summary of current ratings and target prices for Cencora and SBC Medical Group, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Cencora | 0 | 3 | 9 | 0 | 2.75 |
| SBC Medical Group | 0 | 0 | 0 | 0 | 0.00 |
Cencora presently has a consensus price target of $311.25, indicating a potential upside of 4.57%. Given Cencora’s stronger consensus rating and higher probable upside, equities analysts plainly believe Cencora is more favorable than SBC Medical Group.
Risk & Volatility
Cencora has a beta of 0.62, indicating that its stock price is 38% less volatile than the S&P 500. Comparatively, SBC Medical Group has a beta of 1.27, indicating that its stock price is 27% more volatile than the S&P 500.
Profitability
This table compares Cencora and SBC Medical Group’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Cencora | 0.60% | 267.36% | 4.31% |
| SBC Medical Group | 17.71% | 20.76% | 15.56% |
Valuation & Earnings
This table compares Cencora and SBC Medical Group”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Cencora | $293.96 billion | 0.20 | $1.51 billion | $9.72 | 30.62 |
| SBC Medical Group | $205.42 million | 2.52 | $46.61 million | $0.32 | 15.59 |
Cencora has higher revenue and earnings than SBC Medical Group. SBC Medical Group is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks.
Institutional and Insider Ownership
97.5% of Cencora shares are held by institutional investors. Comparatively, 60.8% of SBC Medical Group shares are held by institutional investors. 10.8% of Cencora shares are held by company insiders. Comparatively, 89.5% of SBC Medical Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Summary
Cencora beats SBC Medical Group on 9 of the 14 factors compared between the two stocks.
About Cencora
Cencora, Inc. sources and distributes pharmaceutical products. The company’s U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
About SBC Medical Group
SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand. SBC Medical Group Holdings Incorporated, formerly known as Pono Capital Two Inc., is based in TOKYO.
Receive News & Ratings for Cencora Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Cencora and related companies with MarketBeat.com’s FREE daily email newsletter.
[ad_2]
ABMN Staff
Source link